Journal article
The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
- Abstract:
-
In recent years muscarinic receptor agonists and cholinesterase inhibitors have been developed for the treatment of Alzheimer's disease. We have evaluated examples from both classes of compounds in rodent tests of reference and working memory, as well as tests that are sensitive to the side-effects of these compounds. Thus, three selective muscarinic receptor partial agonists L-689,660, (M1/M3), AF102B (M1/M3) and L-687,306 (M1) and two cholinesterase inhibitors, E2020 and eptastigmine, were ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Behavioural brain research
- Volume:
- 57
- Issue:
- 2
- Pages:
- 143-153
- Publication date:
- 1993-11-01
- DOI:
- EISSN:
-
1872-7549
- ISSN:
-
0166-4328
- Source identifiers:
-
26947
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:26947
- UUID:
-
uuid:02d9cc87-329d-4e8b-b2d8-b5a88beebe73
- Local pid:
- pubs:26947
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 1993
If you are the owner of this record, you can report an update to it here: Report update to this record